Breakthrough Therapy for IgG4-Related Disease Reduces Flares
Inebilizumab offers new hope for managing this chronic autoimmune condition.
Topline
A phase 3 trial reveals that inebilizumab dramatically reduces flares and boosts remission rates in IgG4-related disease, offering a safer, steroid-sparing treatment option.
What is IgG4-Related Disease?
IgG4-related disease (IgG4-RD) is a chronic autoimmune condition marked by fibro-inflammatory lesions in multiple organs, often mimicking cancer. …
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.